Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
112
2.040
 Why?
Thyroidectomy
13
2019
59
1.880
 Why?
Parathyroidectomy
8
2018
46
1.330
 Why?
Thyroid Diseases
6
2019
24
1.280
 Why?
Parathyroid Neoplasms
5
2015
27
1.120
 Why?
Thyroid Gland
7
2017
73
1.070
 Why?
Parathyroid Hormone
8
2019
147
0.980
 Why?
Adenoma
4
2017
111
0.980
 Why?
Vitamin D Deficiency
5
2019
44
0.970
 Why?
Vitamin D
4
2015
88
0.840
 Why?
Fluorodeoxyglucose F18
6
2013
191
0.760
 Why?
Positron-Emission Tomography
7
2013
288
0.750
 Why?
Radiopharmaceuticals
7
2015
205
0.730
 Why?
Carcinoma, Papillary
4
2017
49
0.730
 Why?
Ambulatory Surgical Procedures
4
2014
51
0.710
 Why?
Hyperparathyroidism, Primary
4
2018
35
0.680
 Why?
Hyperparathyroidism
2
2015
31
0.610
 Why?
Iodine Radioisotopes
3
2015
36
0.580
 Why?
Megestrol Acetate
2
2007
17
0.540
 Why?
Parathyroid Diseases
2
2016
5
0.540
 Why?
Bone Density Conservation Agents
2
2007
74
0.520
 Why?
Nursing Homes
2
2007
113
0.520
 Why?
Incidental Findings
3
2013
39
0.490
 Why?
Proton Pump Inhibitors
1
2015
85
0.480
 Why?
Diphosphonates
1
2015
90
0.480
 Why?
Academic Medical Centers
2
2012
147
0.470
 Why?
Thyroglobulin
2
2013
7
0.460
 Why?
Aged
19
2017
9448
0.450
 Why?
Parathyroid Glands
5
2018
20
0.440
 Why?
Carcinoma, Medullary
2
2010
12
0.440
 Why?
Middle Aged
25
2017
12289
0.440
 Why?
Hypothyroidism
2
2011
54
0.400
 Why?
Male
31
2019
25450
0.400
 Why?
Retrospective Studies
14
2019
6124
0.390
 Why?
Postoperative Complications
5
2018
1018
0.380
 Why?
Calcitonin
2
2010
30
0.380
 Why?
Humans
44
2019
49922
0.360
 Why?
Carcinoma
2
2012
139
0.350
 Why?
Algorithms
1
2013
613
0.350
 Why?
Thyroid Nodule
3
2017
31
0.340
 Why?
Female
29
2019
26571
0.320
 Why?
Weight Loss
2
2009
241
0.320
 Why?
Appetite Stimulants
1
2007
5
0.290
 Why?
Aged, 80 and over
9
2017
3137
0.290
 Why?
Cachexia
1
2007
25
0.280
 Why?
Teriparatide
1
2007
10
0.280
 Why?
Four-Dimensional Computed Tomography
2
2017
28
0.270
 Why?
Hypocalcemia
2
2016
12
0.260
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.260
 Why?
Calcium
3
2018
401
0.260
 Why?
Phenylurea Compounds
2
2015
15
0.250
 Why?
Hormones
1
2005
57
0.250
 Why?
Osteoporosis
1
2007
155
0.250
 Why?
Quinolines
2
2015
41
0.250
 Why?
Transcriptional Activation
1
2005
121
0.250
 Why?
Pituitary Gland
1
2005
85
0.240
 Why?
Receptors, Estrogen
1
2005
130
0.240
 Why?
Interleukin-6
1
2005
265
0.230
 Why?
NF-kappa B
1
2005
315
0.220
 Why?
Protein Kinase Inhibitors
2
2015
205
0.220
 Why?
Biopsy, Fine-Needle
5
2011
108
0.220
 Why?
Illinois
2
2013
10
0.210
 Why?
Treatment Outcome
8
2015
5178
0.200
 Why?
Adult
13
2017
13355
0.190
 Why?
Gene Expression Regulation
1
2005
964
0.180
 Why?
Aging
1
2005
669
0.180
 Why?
Young Adult
7
2015
4031
0.180
 Why?
Follow-Up Studies
3
2013
2177
0.170
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.160
 Why?
Postoperative Period
3
2015
170
0.160
 Why?
Preoperative Care
2
2018
167
0.150
 Why?
Vitamins
2
2018
64
0.150
 Why?
Patient Discharge
3
2016
318
0.150
 Why?
Intraoperative Complications
1
2019
113
0.150
 Why?
Insulin Resistance
2
2009
255
0.140
 Why?
United States
5
2015
4880
0.140
 Why?
Prospective Studies
2
2013
2345
0.140
 Why?
Antineoplastic Agents
2
2015
1175
0.140
 Why?
Predictive Value of Tests
3
2015
907
0.130
 Why?
Incidence
2
2011
986
0.130
 Why?
Reoperation
1
2018
454
0.130
 Why?
Adolescent
5
2015
6416
0.130
 Why?
Hypoparathyroidism
1
2015
5
0.130
 Why?
Carcinoma, Neuroendocrine
1
2015
23
0.130
 Why?
Creatinine
1
2015
140
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
49
0.120
 Why?
Costs and Cost Analysis
2
2014
92
0.120
 Why?
Lymph Nodes
1
2017
257
0.120
 Why?
Disease Progression
3
2015
820
0.120
 Why?
Molecular Targeted Therapy
1
2015
121
0.120
 Why?
Ambulatory Care
1
2016
221
0.120
 Why?
Diagnosis, Differential
6
2018
1037
0.120
 Why?
Neoplasm Metastasis
2
2015
235
0.110
 Why?
Child, Preschool
2
2013
3878
0.110
 Why?
Hospitals, University
1
2014
77
0.110
 Why?
Exercise
2
2009
493
0.110
 Why?
Liver
2
2009
1106
0.110
 Why?
Sensitivity and Specificity
2
2013
858
0.110
 Why?
Drug Administration Schedule
1
2013
369
0.110
 Why?
Hospitals, Teaching
1
2013
53
0.110
 Why?
Technetium
1
2012
9
0.100
 Why?
Preoperative Period
1
2012
47
0.100
 Why?
Administration, Oral
1
2013
433
0.100
 Why?
Radionuclide Imaging
1
2012
116
0.100
 Why?
Outpatients
1
2013
112
0.100
 Why?
Patient Compliance
1
2013
230
0.100
 Why?
Clinical Competence
2
2018
396
0.100
 Why?
Hospital Charges
1
2012
44
0.100
 Why?
Struma Ovarii
1
2012
5
0.100
 Why?
Tumor Burden
1
2012
131
0.100
 Why?
Cost Savings
1
2012
58
0.100
 Why?
Prognosis
3
2015
1956
0.100
 Why?
Child
3
2013
6848
0.100
 Why?
Ovariectomy
1
2012
113
0.100
 Why?
Immunohistochemistry
2
2012
972
0.090
 Why?
Obesity
2
2009
1096
0.090
 Why?
Chromogranin A
1
2010
5
0.090
 Why?
Dose-Response Relationship, Drug
1
2013
1354
0.090
 Why?
Radiation Monitoring
1
2010
7
0.090
 Why?
Checklist
1
2010
29
0.090
 Why?
Inpatients
1
2011
193
0.090
 Why?
Radiosurgery
1
2011
120
0.090
 Why?
Fatal Outcome
1
2010
194
0.090
 Why?
Databases, Factual
1
2013
660
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Caloric Restriction
1
2009
34
0.080
 Why?
Ultrasonography
4
2015
429
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
 Why?
Intra-Abdominal Fat
1
2009
21
0.080
 Why?
General Surgery
1
2010
106
0.080
 Why?
Occupational Exposure
1
2010
112
0.080
 Why?
Receptors, Thyrotropin
1
2007
7
0.070
 Why?
Blastomycosis
1
2008
62
0.070
 Why?
Symporters
1
2007
17
0.070
 Why?
Adenoma, Oxyphilic
1
2007
11
0.070
 Why?
Time Factors
3
2015
2891
0.070
 Why?
Whole Body Imaging
1
2007
22
0.070
 Why?
Ovarian Neoplasms
1
2012
450
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Adiposity
1
2009
129
0.070
 Why?
Severity of Illness Index
1
2011
953
0.070
 Why?
DNA, Neoplasm
1
2007
145
0.070
 Why?
Calcifediol
1
2006
8
0.070
 Why?
Practice Management, Medical
1
2006
10
0.070
 Why?
Calcium Carbonate
1
2006
11
0.070
 Why?
Medical Audit
1
2006
21
0.070
 Why?
Drug Utilization Review
1
2006
23
0.070
 Why?
Promoter Regions, Genetic
2
2007
467
0.070
 Why?
Drug Monitoring
1
2006
78
0.070
 Why?
Cross-Sectional Studies
2
2014
1574
0.070
 Why?
Head
1
2006
70
0.070
 Why?
Body Mass Index
2
2009
648
0.070
 Why?
Gene Expression Regulation, Neoplastic
1
2010
824
0.070
 Why?
Geriatrics
1
2006
44
0.070
 Why?
Otolaryngology
1
2006
58
0.070
 Why?
Neck
1
2006
99
0.070
 Why?
Proportional Hazards Models
1
2007
404
0.070
 Why?
Progesterone Congeners
1
2005
5
0.060
 Why?
Body Fat Distribution
1
2005
9
0.060
 Why?
Freezing
1
2005
16
0.060
 Why?
Faculty, Medical
1
2006
92
0.060
 Why?
Fractures, Bone
1
2006
105
0.060
 Why?
Arkansas
2
2014
1989
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Survival Analysis
1
2007
670
0.060
 Why?
DNA Primers
1
2005
208
0.060
 Why?
Reproducibility of Results
3
2017
1182
0.060
 Why?
HeLa Cells
1
2005
257
0.060
 Why?
Internship and Residency
1
2010
442
0.060
 Why?
Base Sequence
1
2005
657
0.060
 Why?
Nuclear Proteins
1
2005
242
0.060
 Why?
Infant
1
2012
3574
0.060
 Why?
Protein Binding
1
2005
656
0.060
 Why?
ROC Curve
2
2015
225
0.050
 Why?
Patient Selection
2
2018
254
0.050
 Why?
Intraoperative Period
2
2015
45
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
550
0.050
 Why?
Tomography, X-Ray Computed
3
2012
1153
0.050
 Why?
Thalidomide
1
2002
374
0.040
 Why?
Cohort Studies
2
2015
1403
0.040
 Why?
Glucagon
2
2009
22
0.040
 Why?
Monitoring, Intraoperative
1
2019
54
0.040
 Why?
Cholecalciferol
1
2018
22
0.040
 Why?
Hospitals, High-Volume
1
2018
25
0.040
 Why?
Medical History Taking
1
2018
47
0.040
 Why?
Risk Factors
1
2006
3604
0.040
 Why?
Pilot Projects
2
2010
702
0.040
 Why?
Lymphatic System
1
2017
13
0.040
 Why?
Methylene Blue
1
2017
10
0.040
 Why?
Societies, Medical
1
2018
177
0.040
 Why?
Animals, Genetically Modified
1
2017
48
0.040
 Why?
Coloring Agents
1
2017
67
0.040
 Why?
Mice, Inbred Strains
1
2017
160
0.030
 Why?
Insulin
2
2009
453
0.030
 Why?
Proto-Oncogene Proteins B-raf
1
2017
78
0.030
 Why?
Recurrence
1
2018
658
0.030
 Why?
Lymphatic Metastasis
1
2017
226
0.030
 Why?
Bone Density
1
2018
383
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
18
0.030
 Why?
Retreatment
1
2015
56
0.030
 Why?
Brachial Plexus
1
2015
11
0.030
 Why?
Endocrinology
1
2015
9
0.030
 Why?
Axilla
1
2015
90
0.030
 Why?
Hematoma
1
2015
64
0.030
 Why?
Transplantation, Autologous
1
2015
462
0.030
 Why?
Neoplasm Staging
1
2015
749
0.030
 Why?
Hernia, Abdominal
1
2012
4
0.030
 Why?
Activating Transcription Factor 1
1
2012
22
0.020
 Why?
Delayed Diagnosis
1
2012
23
0.020
 Why?
Mutation
1
2017
1292
0.020
 Why?
Ribs
1
2010
15
0.020
 Why?
Thoracotomy
1
2010
35
0.020
 Why?
Neck Dissection
1
2010
30
0.020
 Why?
Mediastinal Neoplasms
1
2010
19
0.020
 Why?
Hypercalcemia
1
2010
33
0.020
 Why?
Feasibility Studies
1
2011
382
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
66
0.020
 Why?
Hospitalization
1
2014
663
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Prevalence
1
2012
956
0.020
 Why?
Glucose Tolerance Test
1
2009
56
0.020
 Why?
Adiponectin
1
2009
44
0.020
 Why?
Postmenopause
1
2009
76
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
234
0.020
 Why?
Absorptiometry, Photon
1
2009
152
0.020
 Why?
Eye
1
2008
24
0.020
 Why?
Bone Neoplasms
1
2010
178
0.020
 Why?
Iodine
1
2007
10
0.020
 Why?
Methylation
1
2007
118
0.020
 Why?
Body Weight
1
2009
512
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
626
0.020
 Why?
Multiple Myeloma
1
2002
2916
0.020
 Why?
Overweight
1
2009
213
0.020
 Why?
Current Procedural Terminology
1
2006
7
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Mice
1
2017
5658
0.020
 Why?
Office Visits
1
2006
41
0.020
 Why?
Polymerase Chain Reaction
1
2007
456
0.020
 Why?
Blood Glucose
1
2009
432
0.020
 Why?
Genetic Predisposition to Disease
1
2009
507
0.020
 Why?
Risk Assessment
1
2010
1254
0.020
 Why?
Lung
1
2008
501
0.010
 Why?
Muscle, Skeletal
1
2009
769
0.010
 Why?
Thyroid Function Tests
1
2002
24
0.010
 Why?
Thyrotropin
1
2002
47
0.010
 Why?
Animals
1
2017
13100
0.010
 Why?
Clinical Trials as Topic
1
2002
466
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department